Francisco José Muruzábal-rekin lankidetzan egindako argitalpenak (24)

2022

  1. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 1, pp. 31-45

2021

  1. Membrane of plasma rich in growth factors in primary pterygium surgery compared to amniotic membrane transplantation and conjunctival autograft

    Journal of Clinical Medicine, Vol. 10, Núm. 23

2020

  1. Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases

    European Journal of Ophthalmology, Vol. 30, Núm. 1, pp. 94-103

2018

  1. Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)

    PLoS ONE, Vol. 13, Núm. 10

  2. Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

    International Medical Case Reports Journal, Vol. 11, pp. 97-103

  3. Plasma rich in growth factors for the treatment of dry eye after LASIK surgery

    Ophthalmic Research, Vol. 60, Núm. 2, pp. 80-86

  4. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

    Medicine (United States), Vol. 97, Núm. 17

  5. Searching for the best blood-derived eye drops

    Eye (Basingstoke)

  6. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops

    International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204

2017

  1. Allogeneic blood-based therapies: Hype or hope?

    Eye (Basingstoke)

  2. Subconjunctival PRGF Fibrin Membrane as an Adjuvant to Nonpenetrating Deep Sclerectomy: A 2-Year Pilot Study

    Ophthalmic Research, Vol. 59, Núm. 1, pp. 45-52

  3. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 391-399

2016

  1. Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration

    Platelets, Vol. 27, Núm. 5, pp. 459-466

  2. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model

    Experimental Eye Research, Vol. 151, pp. 115-121

  3. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases

    Current Eye Research, Vol. 41, Núm. 7, pp. 875-882

2015

  1. Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies

    Acta Ophthalmologica, Vol. 93, Núm. 8, pp. e605-e614

  2. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts

    Experimental Eye Research, Vol. 135, pp. 118-126

  3. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops after Their Different Time and Temperature Conditions of Storage

    Cornea, Vol. 34, Núm. 9, pp. 1144-1148

2014

  1. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop

    Experimental Eye Research, Vol. 119, pp. 27-34

2013

  1. Biological stability of plasma rich in growth factors eye drops after storage of 3 months

    Cornea, Vol. 32, Núm. 10, pp. 1380-1386